https://www.novumpr.nl/2019/10/16/ipsen-and-blueprint-medicines-announce-exclusive-global-license-agreement-to-develop-and-commercialize-blu-782-for-the-treatment-of-fibrodysplasia-ossificans-progressiva-fop/?utm_source=rss&utm_medium=rss&utm_campaign=ipsen-and-blueprint-medicines-announce-exclusive-global-license-agreement-to-develop-and-commercialize-blu-782-for-the-treatment-of-fibrodysplasia-ossificans-progressiva-fop NovumPR press releases Wed, 16 Oct 2019 07:29:32 +0000 hourly 1 https://wordpress.org/?v=6.8.3